| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |
| mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.0017 |
1 |
| mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.0025 |
1 |
| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.0026 |
1 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
1 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
| mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
| mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.0014 |
1 |